Haemonetics makes plasma collection devices, blood processing equipment and hospital products for plasma centers, blood centers and hospitals. HAE reports earnings on Thu, Nov 5, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (6 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in HAE, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print.
Prices, price targets and earnings estimates for HAE are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HAE is in one of them and how their past HAE trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Haemonetics
Haemonetics is a medical technology company based in Massachusetts. It makes automated plasma collection systems, donor management software and related disposables for plasma collection centers, mainly those that gather plasma for pharmaceutical makers. It also sells blood collection and processing equipment to blood centers, and surgical and blood management products such as vascular closure devices and cell salvage systems to hospitals.
